s6y
Company name or ticker
Search
Verve Therapeutics, Inc.
4
Kathiresan Sekar: Statement of changes in beneficial ownership of securities
Filed
Thursday, July 21, 2022
Period
Jul 19, 2022
Accession number
0001209191-22-042871
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header